Protective effects of boron on cyclophosphamide induced lipid peroxidation and genotoxicity in rats

Chemosphere

Volumn 108, Issue , 2014, Pages 197-204

  Ince, Sinan ^a   Kucukkurt, Ismail ^a   Demirel, Hasan Huseyin ^a   Acaroz, Damla Arslan ^a   Akbel, Erten ^b   Cigerci, Ibrahim Hakki ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b USAK UNIVERSITY   (Turkey)

Author keywords

Boron; Cyclophosphamide; Genotoxicity; Lipid peroxidation; Rat

Indexed keywords

ANTIOXIDANTS; BLOOD; BORON; BRAIN; ENZYMES; HISTOLOGY; LIPIDS; OXIDATION; OXIDATIVE STRESS; RATING; SODIUM CHLORIDE; TISSUE;

ANTIOXIDANT DEFENCE; CYCLOPHOSPHAMIDE; GENOTOXICITIES; LIPID PEROXIDATION; MONONUCLEAR LEUKOCYTES; PHYSIOLOGICAL SALINE; PLASMA ANTIOXIDANT ACTIVITIES; SUPEROXIDE DISMUTASE ACTIVITIES;

RATS;

BORON; CATALASE; CYCLOPHOSPHAMIDE; DNA; GLUTATHIONE; HEMOGLOBIN; MALONALDEHYDE; NITRIC OXIDE;

BORON; DIET; DNA; ENZYME ACTIVITY; GENOTOXICITY; HISTOPATHOLOGY; LIPID; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; ERYTHROCYTE; GENOTOXICITY; HEART; IMMUNOSUPPRESSIVE TREATMENT; LIPID PEROXIDATION; LUNG; MALE; NONHUMAN; OXIDATIVE STRESS; PLASMA; RAT; ULTRAVIOLET SPECTROPHOTOMETRY;

RATTUS; RODENTIA;

BORON; CYCLOPHOSPHAMIDE; GENOTOXICITY; LIPID PEROXIDATION; RAT;

ANIMALS; BORON; CATALASE; CYCLOPHOSPHAMIDE; DNA DAMAGE; ERYTHROCYTES; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NITRIC OXIDE; PROTECTIVE AGENTS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 84901589115     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2014.01.038     Document Type: Article

References (63)

1. Abraham P., Indirani K., Sugumar E. Effect of cyclophosphamide treatment on selected lysosomal enzymes in the kidney of rats. Exp. Toxicol. Pathol. 2007, 59:143-149.
2. Aebi H. Catalase in vitro. Methods of Enzymatic Analysis 1974, 673-677. Academic Press, New York and London. U. Bergmeyer (Ed.).
3. Alfieri A., Gardner C. The NK1 antagonist GR 203040 inhibits cyclophosphamide-induced damage in the rat and ferret bladder. Gen. Pharmacol. 1997, 29:245-250.
4. Alsaif M.A. Inhibition of gastric mucosal damage by boric acid pretreatment in rats. J. Med. Sci. 2004, 4:102-109.
5. Armstrong T.A., Spears J.W., Lloyd K.E. Inflammatory response, growth, and thyroid hormone concentrations are affected by long-term boron supplementation in gilts. J. Anim. Sci. 2001, 79:1549-1556.
6. Bergendi L., Benes L., Durackova Z., Ferencik M. Chemistry, physiology and pathology of free radicals. Life Sci. 1999, 65:1865-1874.
7. Beutler E., Duron O., Kelly B.M. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 1993, 61:882-888.
8. Bhattacharya A., Lawrence R.A., Krishnan A., Zaman K., Sun D., Fernandes G. Effect of dietary n-3 and n-6 oils with and without food restriction on activity of antioxidant enzymes and lipid peroxidation in livers of cyclophosphamide treated autoimmuneprone NZB/W female mice. J. Am. Coll. Nutr. 2003, 22:388-399.
9. Buerge I.J., Buser H.R., Poiger T., Muller M.D. Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters. Environ. Sci. Technol. 2006, 40:7242-7250.
10. Devirian T.A., Volpe S.L. The physiological effects of dietary boron. Crit. Rev. Food Sci. Nutr. 2003, 43:219-231.
11. Dollery C. Therapeutic Drugs 1999, Churchill Livingstone, Edinburgh, pp C349-C354.
12. Drabkin D.L., Austin J.H. Spectrophotometric studies. II. Preparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin. J. Biol. Chem. 1935, 112:51-65.
13. Draper H.H., Hardley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990, 186:421-431.
14. Farrell M., Sakić B., Szechtman H., Denburg J.A. Effect of cyclophosphamide on leukocytic infiltration in the brain of MRL/lpr mice. Lupus 1997, 6:268-274.
15. Faure H., Coudray C., Mousseau M., Ducros V., Douki T., Bianchini F., Cadet J., Favier A. 5-Hydroxymethyluracil excretion, plasma TBARS and plasma antioxidant vitamins in adriamycin-treated patients. Free Rad. Biol. Med. 1996, 20:979-983.
16. Franssen C., Boekema P., De Witte T., Wessels J., Van der Kogel A., Haanen C. DNA strand breaks in human leukocytes induced by chemotherapy and total body irradiation. Leuk. Res. 1990, 14:91-97.
17. Gregoire V., Begg A.C., Huiskamp R., Verrijk R., Bartelink H. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-bronophenylalanine and boric acid in murine tumors. Radiother. Oncol. 1993, 27:46-54.
18. Hunt C.D. Biochemical effects of physiological amounts of dietary boron. J. Trace Elem. Exp. Med. 1996, 9:185-213.
19. Ince S., Kucukkurt I., Cigerci I.H., Fidan A.F., Eryavuz A. The effects of dietary boric acid and borax supplementation on lipid peroxidation, antioxidant activity, and DNA damage in rats. J. Trace Elem. Med. Biol. 2010, 24:161-164.
20. Ince S., Kucukkurt I., Demirel H.H., Turkmen R., Sever E. Thymoquinone attenuates cypermethrin induced oxidative stress in Swiss albino mice. Pest. Biochem. Physiol. 2012, 104:229-235.
21. Ince S., Keles H., Erdogan M., Hazman O., Kucukkurt I. Protective effect of boric acid against carbon tetrachloride-induced hepatotoxicity in mice. Drug Chem. Toxicol. 2012, 35:285-292.
22. Jolivet J., Cowan K.H., Curt G.A., Clendeninn N.J., Chabner B.A. The pharmacology and clinical use of methotrexate. N. Engl. J. Med. 1983, 309:1094-1104.
23. Kocyigit A., Keles H., Selek S., Guzel S., Celik H., Erel O. Increased DNA damage and oxidative stress in patients with cutaneous leishmaniasis. Mutat. Res. 2005, 585:71-78.
24. Koracevic F., Koracevic G., Djordjevic V., Andrejevic S., Cosic V. Method for the measurement of antioxidant activity in human fluids. Clin. Pathol. 2001, 54:356-361.
25. Kucukkurt I., Ince S., Fidan A.F., Ozdemir A. The effects of dietary supplementation of different amount of Yucca schidigera powder (Sarsaponin 30®) on blood and tissue antioxidant defense systems and lipid peroxidation in rats. J. Anim. Vet. Adv. 2008, 7:1413-1417.
26. Kucukkurt I., Ince S., Aytekin I., Birdane Y.O. The effects of flumethrin and flumethrin+vitamin C application on oxidative stress biomarkers in Chios sheep. Kocatepe Vet. J. 2010, 3:13-17.
27. Kuo C.Y., Wu H.L., Kou H.S., Chiou S.S., Wu D.C., Wu S.M. Simultaneous determination of methotrexate and its eight metabolites in human whole blood by capillary zone electrophoresis. J. Chromatogr. A 2003, 1014:93-101.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
29. Luck H. Catalase. Methods in Analysis 1955, Academy Press, London. H.U. Bergmeyer (Ed.).
30. Maccubbin A.E., Caballes L., Riordan J.M., Huang D.H., Gurtoo H.L. A cyclophosphamide/DNA phosphoester adduct formed in vitro and in vivo. Cancer Res. 1991, 51:886-892.
31. Manda K., Bhatia A.L. Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice. Cell. Biol. Toxicol. 2003, 19:367-372.
32. Martin R.F., D'Cunha G., Pardee M., Allen B.J. Induction of DNA double-strand breaks by 157Gd neutron capture. Pigment Cell Res. 1989, 2:330-332.
33. Meacham S.L., Taper L.J., Volpe S.L. Effects of boron supplementation on bone mineral density and dietary, blood, and urinary calcium, phosphorus, magnesium, and boron in female athletes. Environ. Health Perspect. 1994, 102:79-82.
34. Miranda K.M., Espey M.G., Wink A.D. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001, 5:62-71.
35. Moroni G., Maccario M., Fargion S., Ponticelli G. Severe and prolonged jaundice in a lupus nephritis patient treated with cyclophosphamide. Nephrol. Dial. Transplant. 1997, 12:793-796.
36. Morre F.R., Urda G.A., Krishna G. An in vivo/in vitro method for assessing micronucleus and chromosome aberration induction in rat bone marrow and spleen 1. Studies with cyclophosphamide. Mut. Res. 1995, 335:191-199.
37. Murata M., Suzuki T., Midorikawa K., Oikawa S., Kawanishi S. Oxidative DNA damage by a hydroperoxide derivative of cyclophosphamide. Free Rad. Biol. Med. 2004, 37:793-802.
38. Murray F.J. A comparative review of the pharmacokinetics of boric acid in rodents and humans. Biol. Trace Elem. Res. 1998, 66:331-341.
39. Nagi M.N., Almakki H.A. Thymoquinone supplementation induces quinone reductase and glutathione transferase in mice liver: possible role in protection against chemical carcinogenesis and toxicity. Phytother. Res. 2009, 23:1295-1298.
40. Nielsen F.H. Nutritional requirements for boron, silicon, vanadium, nickel and arsenic: current knowledge and speculation. FASEB J. 1991, 5:2661-2667.
41. Nielsen F.H., Hunt C.D., Mullen L.M., Hunt J.R. Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women. FASEB J. 1987, 1:394-397.
42. Oboh G., Akomolafe T.L., Adefegha S.A., Adetuyi A.O. Inhibition of cyclophosphamide-induced oxidative stress in rat brain by polar and non-polar extracts of Annatto (Bixa orellana) seeds. Exp. Toxicol. Pathol. 2011, 63:257-262.
43. Ognjanović N.Z., Djordjević M.M., Matić J.M., Obradović J.M., Mladenović A.Š., Štajn A.Š., Saičić Z.S. Lipid peroxidative damage on cisplatin exposure and alterations in antioxidant defense system in rat kidneys: a possible protective effect of selenium. Branka I. Int. J. Mol. Sci. 2012, 13:1790-1803.
44. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
45. Popovic M., Kolarovic J., Mikov M., Trivic S., Kaurinovic B. Anthracycline-based combined chemotherapy in the mouse model. Eur. J. Drug Metab. Pharmacokinet. 2007, 32:101-108.
46. Premkumar K., Pachiappan A., Abraham S.K., Santhiya S.T., Gopinath P.M., Ramesh A. Effect of Spirulina fusiformis on cyclophosphamide and mitomycin-C induced genotoxicity and oxidative stress in mice. Fitoterapia 2001, 72:906-911.
47. Primus F.J., Pak R.H., Richard-Dickson K.J., Szalai G., Bolen J.L., Kane R.R., Hawthorne M.F. Bispecific antibody mediated targeting of nido-carboranes to human colon carcinoma cells. Bioconjug. Chem. 1996, 7:532-535.
48. Sayed-Ahmed M.M. Progression of cyclophosphamide-induced acute renal metabolic damage in carnitine-depleted rat model. Clin. Exp. Nephrol. 2010, 14:418-426.
49. Selvakumar E., Prahalathan C., Sudharsan P.T., Varalakshmi P. Chemoprotective effect of lipoic acid against cyclophosphamide-induced changes in the rat sperm. Toxicology 2006, 217:71-78.
50. Senthilkumar S., Devaki T., Manohar B.M., Babu M.S. Effect of squalene on cyclophosphamide-induced toxicity. Clin. Chim. Acta 2006, 364:335-342.
51. Singh G., Maulik S.K., Jaiswal A., Kumar P., Parshad R. Effect on antioxidant levels in patients of breast carcinoma during neoadjuvant chemotherapy and mastectomy. Malaysian J. Med. Sci. 2010, 17:24-28.
52. Souza-Filho M.V., Lima M.V., Pompeu M.M., Ballejo G., Cunha F.O., Ribeiro R.de A. Involvement of nitric oxide in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. Am. J. Pathol. 1997, 150:247-256.
53. Stankiewicz A., Skrzydlewska E. Protection against cyclophosphamide-induced renal oxidative stress by amifostine: the role of antioxidative mechanisms. Toxicol. Mech. Meth. 2003, 13:301-308.
54. Stankiewicz A., Skrzydlewska E., Makiela M. Effects of amifostine on liver oxidative stress caused by cyclophosphamide administration to rats. Drug Metabol. Drug Interact. 2002, 19:67-82.
55. Sulkowska M., Skrzydlewska E., Sobaniec-Łotowska M., Famulski W., Terlikowski S., Kańczuga-koda L., Reszeć J., Daniszewska I. Effect of cyclophosphamide-induced generation reactive oxygen forms on ultrastructure of the liver and lung. Bull. Vet. Inst. Pulawy 2002, 46:239-246.
56. Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988, 34:497-500.
57. Tripathi D.N., Jena G.B. Astaxanthin inhibits cytotoxic and genotoxic effects of cyclophosphamide in mice germ cells. Toxicology 2008, 248:96-103.
58. Tripathi D.N., Jena G.B. Intervention of astaxanthin againstcyclophosphamide induced oxidative stress and DNA damage: a study in mice. Chemico-Biol. Int. 2009, 180:398-406.
59. Turkez H., Geyikoglu F., Tatar A., Keles S., Ozkanc A. Effects of some boron compounds on peripheral human blood. Z. Naturforsch. 2007, 62:889-896.
60. Viswanatha-Swamy A.H.M., Patel U.M., Koti B.C., Gadad P.C., Patel N.L., Thippeswamy A.H.M. Cardioprotective effect of Saraca indica against cyclophosphamide induced cardiotoxicity in rats: a biochemical, electrocardiographic and histopathological study. Indian J. Pharmacol. 2013, 45:44-48.
61. Winterbourn C.C., Hawkins R.E., Brain M., Carrell R.W. The estimation of red cell superoxide activity. J. Lab. Clin. Med. 1975, 55:337-341.
62. Xu X., Malavé A. Protective effect of berberine on cyclophosphamide-induced haemorrhagic cystitis in rats. Pharmacol. Toxicol. 2001, 88:232-237.
63. Zhang Q.H., Wu C.F., Duan L., Yang J.Y. Protective effects of ginsenoside Rg (3) against cyclophosphamide-induced DNA damage and cell apoptosis in mice. Arch. Toxicol. 2008, 82:117-123.